Freeport-McMoran beats second-quarter profit estimates-February 2024-www.financetom.com

Freeport-McMoran beats second-quarter profit estimates

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Freeport-McMoran beats second-quarter profit estimates

Jul 23, 2024 5:29 AM

July 23 (Reuters) - Miner Freeport-McMoran beat

second-quarter profit estimates on Tuesday, benefiting from

higher copper prices.

The company reported an adjusted profit of 46 cents per

share for the quarter ended June 30, compared with analysts'

average estimate of 38 cents, according to LSEG data.

(Reporting by Tanay Dhumal in Bengaluru)

Previous page： --Horace Mann Educators Keeps Quarterly Dividend at $0.34 a Share, Payable Sept. 30 to Holders of Record Sept. 16 Next page： Accuray Chief Executive to Take Temporary Medical Leave of Absence

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Horace Mann Educators Keeps Quarterly Dividend at $0.34 a Share, Payable Sept. 30 to Holders of Record Sept. 16

Sep 5, 2024

05:29 PM EDT, 09/03/2024 (MT Newswires) -- Price: 36.22, Change: -0.01, Percent Change: -0.03 ...

Accuray Chief Executive to Take Temporary Medical Leave of Absence

Sep 5, 2024

05:28 PM EDT, 09/03/2024 (MT Newswires) -- Accuray ( ARAY ) said late Tuesday that Chief Executive and President Suzanne Winter will take a temporary medical leave of absence, effective immediately, to receive care for a treatable form of cancer. The company appointed Chief Commercial Officer Sandeep Chalke as interim CEO. ...

Element Solutions to Sell Flexographic Printing Plate Business for $325 Million

Sep 5, 2024

05:23 PM EDT, 09/03/2024 (MT Newswires) -- Element Solutions ( ESI ) said Tuesday it agreed to sell its noncore flexographic printing plate business, MacDermid Graphics Solutions, to XSYS for an enterprise value of roughly $325 million. The company said an existing capital loss is expected to offset almost all taxable gains from the transaction. It plans to use the...

Ascendis Pharma Q2 Loss Narrows, Sales Slump -- Shares Plunge After Hours

Sep 5, 2024

05:21 PM EDT, 09/03/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) reported a Q2 loss late Tuesday of 1.91 euros ($2.11) per diluted share, compared with a 2.16 euros loss a year earlier. Analysts polled by Capital IQ expected a loss of 1.34 euros. Revenue for the quarter that ended June 30 was 36 million euros, down from 47.4...